Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
559,556
-
Shares change
-
+320,196
-
Total reported value, excl. options
-
$222,000
-
Value change
-
+$128,766
-
Number of buys
-
6
-
Number of sells
-
-1
-
Price
-
$0.4022
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2017
8 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q2 2017.
IGC Pharma, Inc. - COM NEW (IGC) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 559,556 shares
.
Largest 9 shareholders include Virtu KCG Holdings LLC (281,304 shares), PANAGORA ASSET MANAGEMENT INC (93,354 shares), UBS Group AG (71,722 shares), Creative Planning (65,049 shares), CITADEL ADVISORS LLC (23,776 shares), DEUTSCHE BANK AG\ (11,475 shares), Bank of New York Mellon Corp (10,000 shares), ACADIAN ASSET MANAGEMENT LLC (2,876 shares), and LADENBURG THALMANN FINANCIAL SERVICES INC. (1,500 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.